Zobrazeno 1 - 10
of 48
pro vyhledávání: ''
Autor:
Malcolm R. Kell, Siun M Walsh, John Mitchel Barry, M. Kennedy, F. Flanagan, Emma C Dunne, Maurice Stokes, Patrick A Boland, Akvile Kovanaite
Publikováno v:
The Breast Journal. 26:2383-2390
Introduction Lobular neoplasia is a term encompassing both atypical lobular hyperplasia and lobular carcinoma in situ. These pathological findings are of uncertain malignant potential and predispose to a higher lifetime risk of breast cancer. Debate
Publikováno v:
The Breast Journal. 26:2350-2356
The lobular carcinoma in situ (LCIS) subtypes include classic (CLCIS), pleomorphic (PLCIS), and florid LCIS (FLCIS). The CLCIS is considered a breast cancer risk factor, but clinical significance and natural history of other LCIS subtypes are unclear
Publikováno v:
The Breast Journal. 26:1148-1155
The designation of noninvasive lobular neoplasia applies to atypical epithelial proliferations composed of noncohesive cells secondary to loss or functional alteration of E-cadherin-mediated cell adhesion. The morphologic spectrum of noninvasive lobu
Autor:
Michael D. Lagios
Publikováno v:
The Breast Journal. 26:1132-1137
In the recent past, DCIS was a rare diagnosis established by biopsy of palpable breast masses or nipple changes. Mammography increased the frequency of a DCIS diagnosis by 20 × resulting in a tsunami of small circa 10 mm lesions detected only by mam
Publikováno v:
The Breast Journal. 27:173-175
Secondary angiosarcoma of the breast following catheter-based brachytherapy after lumpectomy is rare. We describe a case of a patient with breast cancer treated with partial mastectomy and sentinel node biopsy followed by accelerated partial breast i
Autor:
Marta Bertolo Domínguez, Sandra Díaz Sierra, Marta Hernandorena González, María del Carmen Azorín Samper, Alberto Ibáñez Arias, Félix Checa Ayet
Publikováno v:
The Breast Journal. 26:252-254
Breast pseudoaneurysms after a core needle biopsy are a rare complication with a low incidence. However, it is important to be aware of the possibility of complications that require treatment.
Autor:
Allison Cauthen, Paul S. Dale, Betsy Smith, Christopher J Jean-Louis, Allison Lord, Ahkeel Allen
Publikováno v:
The Breast Journal. 25:103-106
Excision of high-risk breast lesions (HRL) continues to be standard of care. Previous studies have shown that HRLs can be upgraded to carcinoma in situ (CIS) or invasive carcinoma (IC) upon excision. A single institution retrospective review was cond
Autor:
Esther Dubrovsky, Shira Schwartz, Samantha Raymond, Pauline Nguyen, Freya Schnabel, Amber A. Guth, Naamit K. Gerber, Jennifer Chun
Publikováno v:
The Breast Journal. 24:971-975
BACKGROUND The treatment of ductal carcinoma in situ (DCIS) remains controversial and may be particularly difficult for patients with minimal disease. There is a dearth of information regarding patients who have been diagnosed with DCIS on core needl
Publikováno v:
The Breast Journal. 24:644-647
Neuroendocrine carcinoma of the breast is a rare tumor subtype comprising less than 1% of breast cancers in the United States. Merkel cell features within this rare subtype are even rarer. We report a neuroendocrine breast carcinoma with Merkel cell
Autor:
Hans-Peter Sinn, Felix K. F. Kommoss, B Schäfgen, Christina Gomez, Katharina Kriegsmann, Benjamin Goeppert, Mark Kriegsmann, Ewgenija Gutjahr, Christa Flechtenmacher, Jörg Heil
Publikováno v:
The Breast Journal. 25:1251-1253
Recently, it has been reported that IgG4-related disease may occur in the breast manifesting as nodular sclerosing interstitial mastitis. Here we report a case with multiple tumor-like nodules in one breast. The histologic diagnosis was established o